AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI)

Historical Holders from Q2 2024 to Q1 2025

Symbol
ATXI on OTC
Type / Class
Equity / Common Stock, $0.0001 Par Value
Shares outstanding
3,191,709
All holders as of 31 Mar 2025
Q1 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-7
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Fortress Biotech, Inc. 10.3% -25% $82,186 +$8,431 328,746 +11% Fortress Biotech, Inc. 31 Mar 2025
Ikarian Capital, LLC 6.8% $35,000 140,000 Ikarian Capital, LLC 31 Dec 2024
ARMISTICE CAPITAL, LLC 4.99% $25,100 100,400 Armistice Capital, LLC 31 Dec 2024

Institutional Holders of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q1 0 $0 -$385,256 0
2024 Q4 192,628 $385,256 -$102,432 $2 7
2024 Q3 197,515 $491,813 +$202,123 $2.49 8
2024 Q2 116,349 $407,223 +$407,223 $3.5 8